Cited 0 times in 
Cited 0 times in 
Pembrolizumab with or without chemotherapy versus chemotherapy alone for patients with PD-L1-positive advanced gastric or gastroesophageal junction adenocarcinoma: Update from the phase 3 KEYNOTE-062 trial
https://orcid.org/0000-0002-0920-9471Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.